ACADEMIA

• NCC, BrightPath Identify Peptide Vaccine Candidates for COVID-19
  July 31, 2020

• Avigan Fails to Hit Statistical Significance in COVID-19 Trial: Fujita Health Univ.
  July 13, 2020

• Univ. of Tokyo, Biogen Expand Neurological Research Program for 2 Years
  July 9, 2020

• Kyoto University, NIBIOHN to Join Forces on Drug Discovery
  July 8, 2020

• Nobel Laureate Honjo Sues Ono over Opdivo Royalties, Demands 22.6 Billion Yen
  June 22, 2020

• NIID Aims to Start Preclinical Trials for Coronavirus Vaccines in Autumn: Flu Center Director
  June 10, 2020

• Remdesivir Not Used as Severe Cases Decreased, Avigan/Alvesco Given to Several Dozen Patients: TMDU Hospital
  June 5, 2020

• AnGes/Osaka Univ. Plan Small COVID-19 Vaccine Study from July, Larger One from September
  June 5, 2020

• Kyoto Univ. to Launch Alzheimer’s Trial: iPSC-Based Drug Repositioning Project
  June 5, 2020

• Japan to Join NIH’s Remdesivir-Baricitinib Combo Trial for COVID-19
  June 1, 2020

• 26 Patients Enrolled in Alvesco’s Novel Coronavirus Trial: NCGM
  June 1, 2020

• Nagasaki Univ. to Launch Clinical Trial for Nelfinavir for COVID-19
  May 28, 2020

• Most Mild COVID-19 Patients Recovered on Avigan, but Careful Interpretations Needed for Single-Arm Study: Interim Report
  May 27, 2020

• Discontinued HIV Med Nelfinavir Hits Limelight as Potential COVID-19 Treatment
  May 26, 2020

• Avigan Interim Analysis Not Intended to Determine Efficacy, Research Sponsor Says on Reports
  May 21, 2020

• Infection Society's Updated COVID-19 Guide Includes Information on Veklury
  May 15, 2020

• Investigator Calls for Early Listing of Zolgensma in Japan
  May 12, 2020

• Univ. of Tokyo Starts Testing Avigan Plus Futhan for COVID-19
  May 11, 2020

• 5-Year Cancer Survival Rates Up 2 Points to 64.1%: NCC
  April 17, 2020

• Gunma Univ. Hospital Plans Clinical Research Covering Hydroxychloroquine
  April 13, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• …
• Next ›
• 最終 »